Enact Holdings Inc.· ACT
🇺🇸 US · MidSP600NASDAQ
- Price
- $47.89
- Day
- +0.02%
- Mkt Cap
- $6.69B
- 52W Range
- $34.64 – $48.79
- Volume
- 381.5K
- Beta
- 0.46
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, protecting antiviral peptide conjugates, the methods used to make them, their formulations, and the design platform behind them CAMBRIDGE, Mass., Aug. 3, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced continued expansion of its intellectual property portfolio, which now comprises seven patent families covering compositions of matter, methods of manufacture, formulations, and the company's IMP³ACT™ design platform.
Read full article
SEATTLE, July 30, 2026 /PRNewswire/ -- ACT Capital Advisors today announced that it has secured $30 million in development line financing from Pathward®, N.A. on behalf of Teichos Energy, LLC, a utility-scale renewable energy developer.
Read full article
Enact Holdings (ACT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
LONDON, Ontario, July 16, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that its collaboration with ECOCE, A.C.
Read full article